Lanxia Zhao

513 total citations
10 papers, 451 citations indexed

About

Lanxia Zhao is a scholar working on Biomaterials, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Lanxia Zhao has authored 10 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomaterials, 6 papers in Organic Chemistry and 6 papers in Molecular Biology. Recurrent topics in Lanxia Zhao's work include Nanoparticle-Based Drug Delivery (6 papers), RNA Interference and Gene Delivery (3 papers) and Surfactants and Colloidal Systems (3 papers). Lanxia Zhao is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), RNA Interference and Gene Delivery (3 papers) and Surfactants and Colloidal Systems (3 papers). Lanxia Zhao collaborates with scholars based in China and United States. Lanxia Zhao's co-authors include Yuxia Luan, Longlong Zhang, Zhonghao Li, Kaiming Wang, Lisi Qi, Yue Jiang, Jianmei Pang, Feifei Li, Xiaoqing Ji and Fei Qin and has published in prestigious journals such as Biomaterials, Progress in Polymer Science and Journal of Colloid and Interface Science.

In The Last Decade

Lanxia Zhao

10 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lanxia Zhao China 9 218 166 151 130 87 10 451
Adriana Cambón Spain 17 225 1.0× 170 1.0× 221 1.5× 162 1.2× 158 1.8× 37 632
Manuela Callari Australia 9 185 0.8× 134 0.8× 114 0.8× 71 0.5× 75 0.9× 10 358
Lindomar J. C. Albuquerque Brazil 16 188 0.9× 125 0.8× 158 1.0× 169 1.3× 156 1.8× 28 527
Leana Travaglini Italy 16 298 1.4× 291 1.8× 171 1.1× 89 0.7× 240 2.8× 24 645
Justin A. Smolen United States 10 137 0.6× 134 0.8× 109 0.7× 120 0.9× 80 0.9× 16 412
Priyanka Ray United States 18 197 0.9× 87 0.5× 170 1.1× 253 1.9× 175 2.0× 35 652
Naphtali O’Connor United States 13 96 0.4× 217 1.3× 208 1.4× 119 0.9× 152 1.7× 23 655
Wei Scarano Australia 10 314 1.4× 182 1.1× 188 1.2× 141 1.1× 107 1.2× 10 535
Yansheng Dong China 10 150 0.7× 224 1.3× 93 0.6× 101 0.8× 118 1.4× 14 491
Yalei Miao China 12 298 1.4× 110 0.7× 88 0.6× 306 2.4× 194 2.2× 15 556

Countries citing papers authored by Lanxia Zhao

Since Specialization
Citations

This map shows the geographic impact of Lanxia Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanxia Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanxia Zhao more than expected).

Fields of papers citing papers by Lanxia Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanxia Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanxia Zhao. The network helps show where Lanxia Zhao may publish in the future.

Co-authorship network of co-authors of Lanxia Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Lanxia Zhao. A scholar is included among the top collaborators of Lanxia Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanxia Zhao. Lanxia Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Meng, Tingting, Yu Tong, Lanxia Zhao, et al.. (2021). Aptamer and Peptide-Modified Lipid-Based Drug Delivery Systems in Application of Combined Sequential Therapy of Hepatocellular Carcinoma. ACS Biomaterials Science & Engineering. 7(6). 2558–2568. 13 indexed citations
2.
Zhao, Lanxia, Xia Zhang, Xin Liu, Juan Li, & Yuxia Luan. (2017). pH‐responsive poly(ethylene glycol)‐poly(ϵ‐caprolactone)‐poly(glutamic acid) polymersome as an efficient doxorubicin carrier for cancer therapy. Polymer International. 66(11). 1579–1586. 10 indexed citations
3.
Li, Juan, Bin Zhang, Jing Wu, et al.. (2017). Strategies to release doxorubicin from doxorubicin delivery vehicles. Journal of drug targeting. 26(1). 9–26. 19 indexed citations
4.
Zhao, Lanxia, et al.. (2015). Polymer assembly: Promising carriers as co-delivery systems for cancer therapy. Progress in Polymer Science. 58. 1–26. 90 indexed citations
5.
Zhao, Lanxia, et al.. (2015). WITHDRAWN: Polymer assembly: Promising carriers as co-delivery systems for cancer therapy. Progress in Polymer Science. 2 indexed citations
6.
Zhao, Lanxia, et al.. (2013). Self-assembly properties, aggregation behavior and prospective application for sustained drug delivery of a drug-participating catanionic system. International Journal of Pharmaceutics. 452(1-2). 108–115. 42 indexed citations
7.
Zhao, Lanxia, et al.. (2013). A review of polypeptide-based polymersomes. Biomaterials. 35(4). 1284–1301. 121 indexed citations
8.
Jiang, Yue, Feifei Li, Yuxia Luan, et al.. (2012). Formation of drug/surfactant catanionic vesicles and their application in sustained drug release. International Journal of Pharmaceutics. 436(1-2). 806–814. 67 indexed citations
9.
Pang, Jianmei, Lanxia Zhao, Longlong Zhang, Zhonghao Li, & Yuxia Luan. (2012). Folate-conjugated hybrid SBA-15 particles for targeted anticancer drug delivery. Journal of Colloid and Interface Science. 395. 31–39. 50 indexed citations
10.
Jiang, Yue, Yuxia Luan, Fei Qin, Lanxia Zhao, & Zhonghao Li. (2012). Catanionic vesicles from an amphiphilic prodrug molecule: a new concept for drug delivery systems. RSC Advances. 2(17). 6905–6905. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026